DE69525633D1 - Chinoxalinderivate und ihre therapeutische verwendbarkeit - Google Patents

Chinoxalinderivate und ihre therapeutische verwendbarkeit

Info

Publication number
DE69525633D1
DE69525633D1 DE69525633T DE69525633T DE69525633D1 DE 69525633 D1 DE69525633 D1 DE 69525633D1 DE 69525633 T DE69525633 T DE 69525633T DE 69525633 T DE69525633 T DE 69525633T DE 69525633 D1 DE69525633 D1 DE 69525633D1
Authority
DE
Germany
Prior art keywords
pct
alkyl
therapeutic use
date mar
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69525633T
Other languages
English (en)
Other versions
DE69525633T2 (de
Inventor
Jonathan Fray
Eric Mowbray
Alan Stobie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Ltd
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd, Pfizer Research and Development Co NV SA filed Critical Pfizer Ltd
Publication of DE69525633D1 publication Critical patent/DE69525633D1/de
Application granted granted Critical
Publication of DE69525633T2 publication Critical patent/DE69525633T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69525633T 1994-09-24 1995-09-08 Chinoxalinderivate und ihre therapeutische verwendbarkeit Expired - Fee Related DE69525633T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419318A GB9419318D0 (en) 1994-09-24 1994-09-24 Therapeutic agents
PCT/EP1995/003559 WO1996009295A1 (en) 1994-09-24 1995-09-08 Quinoxaline derivatives useful in therapy

Publications (2)

Publication Number Publication Date
DE69525633D1 true DE69525633D1 (de) 2002-04-04
DE69525633T2 DE69525633T2 (de) 2002-08-08

Family

ID=10761869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69525633T Expired - Fee Related DE69525633T2 (de) 1994-09-24 1995-09-08 Chinoxalinderivate und ihre therapeutische verwendbarkeit

Country Status (28)

Country Link
US (1) US5852016A (de)
EP (1) EP0783495B1 (de)
JP (1) JP2986920B2 (de)
KR (1) KR970706261A (de)
CN (1) CN1158610A (de)
AT (1) ATE213731T1 (de)
AU (1) AU688591B2 (de)
BR (1) BR9504132A (de)
CA (1) CA2200742C (de)
CO (1) CO4410336A1 (de)
CZ (1) CZ85797A3 (de)
DE (1) DE69525633T2 (de)
DK (1) DK0783495T3 (de)
ES (1) ES2171553T3 (de)
FI (1) FI971193A (de)
GB (1) GB9419318D0 (de)
HU (1) HUT77734A (de)
IL (2) IL115334A0 (de)
MX (1) MX9702259A (de)
NO (1) NO971261L (de)
NZ (1) NZ292922A (de)
PE (1) PE47596A1 (de)
PL (1) PL319405A1 (de)
PT (1) PT783495E (de)
RU (1) RU2135484C1 (de)
TR (1) TR199501158A2 (de)
WO (1) WO1996009295A1 (de)
ZA (1) ZA958023B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
DE69619088T2 (de) * 1995-10-10 2002-07-11 Pfizer Inc., New York Quinoxalin-Derivate zur Behandlung von Tinnitus
GB9604400D0 (en) * 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
WO1997046539A1 (en) * 1996-06-05 1997-12-11 Warner-Lambert Company Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
CN1248249A (zh) * 1997-02-18 2000-03-22 美国家用产品公司 多巴胺激动剂5-氨基烷氧基-1,4-二氢喹喔啉-2,3-二酮类化合物
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
GB0310881D0 (en) * 2003-05-12 2003-06-18 Merck Sharp & Dohme Pharmaceutical formulation
US10208000B2 (en) 2015-12-16 2019-02-19 University Of Kentucky Research Foundation Eis inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE572852C (de) * 1931-03-08 1933-03-24 Willy Messerschmitt Dipl Ing Verfahren zur Herstellung von Flugzeugtragfluegeln mit trapezfoermigem Grundriss
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4123106A1 (de) * 1991-07-09 1993-01-14 Schering Ag Arzneimittel zur behandlung von entzugssymptomen
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5614508A (en) * 1995-06-07 1997-03-25 Warner-Lambert Company Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists

Also Published As

Publication number Publication date
BR9504132A (pt) 1996-08-06
CN1158610A (zh) 1997-09-03
WO1996009295A1 (en) 1996-03-28
CA2200742A1 (en) 1996-03-28
FI971193A (fi) 1997-05-21
NO971261D0 (no) 1997-03-19
MX9702259A (es) 1997-06-28
JP2986920B2 (ja) 1999-12-06
NZ292922A (en) 1998-07-28
ES2171553T3 (es) 2002-09-16
NO971261L (no) 1997-05-05
US5852016A (en) 1998-12-22
AU3523295A (en) 1996-04-09
FI971193A0 (fi) 1997-03-21
DK0783495T3 (da) 2002-04-22
CA2200742C (en) 2001-09-11
EP0783495A1 (de) 1997-07-16
CO4410336A1 (es) 1997-01-09
IL126104A0 (en) 1999-05-09
DE69525633T2 (de) 2002-08-08
IL115334A0 (en) 1995-12-31
PL319405A1 (en) 1997-08-04
GB9419318D0 (en) 1994-11-09
ZA958023B (en) 1997-03-24
KR970706261A (ko) 1997-11-03
RU2135484C1 (ru) 1999-08-27
HUT77734A (hu) 1998-07-28
ATE213731T1 (de) 2002-03-15
TR199501158A2 (tr) 1997-02-21
PE47596A1 (es) 1996-11-12
EP0783495B1 (de) 2002-02-27
JPH09511526A (ja) 1997-11-18
CZ85797A3 (cs) 1998-09-16
PT783495E (pt) 2002-07-31
AU688591B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
DE69409913D1 (de) Methode zur Hemmung der Proliferation weiche Muskelzellen und der Restenose
SE9604786D0 (sv) New compounds
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
SE9703414D0 (sv) New compounds
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DE69525633D1 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
MX9605458A (es) Derivados de amida y su uso terapeutico.
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
DK544689D0 (da) Terapeutisk aktive forbindelser
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE250413T1 (de) 2-aminotetraline zur behandlung von glaukom
ATE220665T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DK0662081T3 (da) Ureidoacetamidderivater, deres fremstilling og lægemidler indeholdende disse derivater
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
NO951798L (no) Terapeutiske midler
ECSP951538A (es) Derivados de quinoxalina utiles en terapia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee